INJECTION SITE DISCHARGE side effect
What is INJECTION SITE DISCHARGE ?
Help Community - Describe Your Side Effect
Search FDA Side Effects
Ask Health Expert
INJECTION SITE DISCHARGE and Recently Reported Side Effects
INJECTION SITE DISCHARGE and 15 most Active Side Effect polls
INJECTION SITE DISCHARGE and featured health surveys
Substances toxic to Health
Recent Hospital reviews
Comments about Side Effects
Hospital Quality reviews
Homecare Quality reviews
Drugs associated with INJECTION SITE DISCHARGE
ETHYOL FUZEON HUMIRA HYDROXYZINE PREDNISOLONE PRIMAXIN REBIF SYMLINEthyol Side Effects Report #5662012-X
Health Professional from UNITED STATES reported ETHYOL problem on May 18, 2007. Female patient, 63 years of age, weighting 160.0 lb, was diagnosed with tonsil cancer and was treated with ETHYOL. After drug was administered, patient experienced the following problems/side effects: injection site discharge, injection site rash, injection site vesicles, nikolsky's sign, rash macular, rash papular, rash pruritic, skin burning sensation, skin injury, . ETHYOL dosage: 500 MG, 5 IN 5 D, SUBCUTANEOUS. During the same period patient was treated with COMPAZINE, BENADRYL. Patient recovered.
Rebif Side Effects Report #5677880-5
REBIF problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2008. Female patient, 22 years of age, weighting 104.7 lb, was diagnosed with multiple sclerosis and was treated with REBIF. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, injection site discharge, . REBIF dosage: unknown. Patient was hospitalized. Patient recovered.
Primaxin Side Effects Report #5620100-8
Pharmacist from UNITED STATES reported PRIMAXIN problem on Jan 29, 2008. Female patient, 54 years of age, weighting 134.5 lb, was diagnosed with mycobacterial infection and was treated with PRIMAXIN. After drug was administered, patient experienced the following problems/side effects: blister, injection site discharge, insomnia, pain, pruritus, pyrexia, rash, swelling, . PRIMAXIN dosage: unknown. During the same period patient was treated with AMIKACIN SULPHATE, AMIKACIN SULPHATE, FUROSEMIDE, MUCINEX, ADVAIR DISKUS, PROVENTIL, NEXIUM. Patient recovered.
Hydroxyzine Side Effects Report #5483750-8
HYDROXYZINE problem was reported by a Health Professional from UNITED STATES on Sept 19, 2007. Female patient, 70 years of age, weighting 138.0 lb, was diagnosed with migraine, nausea and was treated with HYDROXYZINE. After drug was administered, patient experienced the following problems/side effects: injection site cellulitis, injection site discharge, injection site haemorrhage, . HYDROXYZINE dosage: 100 MG INTRAMUSCULAR. Patient recovered.
Symlin Side Effects Report #5383784-8
Consumer or non-health professional from UNITED STATES reported SYMLIN problem on May 14, 2007. Female patient, 64 years of age, was diagnosed with type 2 diabetes mellitus and was treated with SYMLIN. After drug was administered, patient experienced the following problems/side effects: injection site discharge, injection site pain, . SYMLIN dosage: unknown. During the same period patient was treated with NOVOLOG, LANTUS, LOVENOX. Patient recovered.
Prednisolone Side Effects Report #5401972-9
PREDNISOLONE problem was reported by a Physician from JAPAN on July 17, 2007. Male patient, 50 years of age, was diagnosed with behcet's syndrome, uveitis and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: eyelid oedema, injection site discharge, nocardiosis, orbital infection, post procedural infection, retinitis, uveitis, vision blurred, visual acuity reduced, . PREDNISOLONE dosage: 7.5 MG, QD, ORAL. During the same period patient was treated with BETAMETHASONE, TRIAMCINOLONE, ASPIRIN, COLISTIN, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.
Symlin Side Effects Report #5383784-8
Consumer or non-health professional from UNITED STATES reported SYMLIN problem on May 14, 2007. Female patient, 64 years of age, was diagnosed with type 2 diabetes mellitus and was treated with SYMLIN. After drug was administered, patient experienced the following problems/side effects: injection site discharge, injection site pain, . SYMLIN dosage: unknown. During the same period patient was treated with NOVOLOG, LANTUS, LOVENOX. Patient recovered.
Prednisolone Side Effects Report #5401972-9
PREDNISOLONE problem was reported by a Physician from JAPAN on July 17, 2007. Male patient, 50 years of age, was diagnosed with behcet's syndrome, uveitis and was treated with PREDNISOLONE. After drug was administered, patient experienced the following problems/side effects: eyelid oedema, injection site discharge, nocardiosis, orbital infection, post procedural infection, retinitis, uveitis, vision blurred, visual acuity reduced, . PREDNISOLONE dosage: 7.5 MG, QD, ORAL. During the same period patient was treated with BETAMETHASONE, TRIAMCINOLONE, ASPIRIN, COLISTIN, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.
Humira Side Effects Report #5770695-9
Consumer or non-health professional from UNITED STATES reported HUMIRA problem on May 09, 2008. Female patient, weighting 255.5 lb, was diagnosed with colitis ulcerative, hypothyroidism, hypersensitivity, fluid retention, fibromyalgia, insomnia and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: increased appetite, injection site discharge, injection site erythema, injection site pruritus, injection site urticaria, weight increased, . HUMIRA dosage: unknown. During the same period patient was treated with LEVOTHYROXINE, PREDNISONE, LIALDA, NARINE, MONTELUKAST, FUROSEMIDE, MODAFINIL. Patient recovered.
Fuzeon Side Effects Report #5332318-2
FUZEON problem was reported by a Physician from UNITED STATES on May 21, 2007. Male patient, weighting 298.0 lb, was diagnosed with hiv infection and was treated with FUZEON. After drug was administered, patient experienced the following problems/side effects: injection site atrophy, injection site discharge, lipodystrophy acquired, . FUZEON dosage: 90 MG BID SQ. Patient recovered.